Wonju Severance Christian Hospital

The trials here

What the 8 trials at this site are about, from their registry records.

Conditions

• Fatty liver disease (MASLD/MASH)2 trials
• Heart failure2 trials
• Chronic kidney disease1 trial
• IgA nephropathy1 trial
• Obesity1 trial

Phase

• Phase 34 trials
• Phase 23 trials

Status

• Active, not recruiting2 trials
• Completed2 trials
• Not yet recruiting2 trials
• Recruiting2 trials

Lead sponsor

• Novo Nordisk A/S6 trials
• Alpine Immune Sciences Inc, A Subsidiary of Vertex1 trial
• Korea University1 trial

Running trials

• Not yet recruiting

  A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity

  NCT07861100· Phase 3· Novo Nordisk A/S· Source

  Contact: Novo Nordisk

• Recruiting

  A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy

  NCT06979375· Phase 2· Novo Nordisk A/S· Source

  Contact: Novo Nordisk

• Recruiting

  A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy

  NCT06979362· Phase 2· Novo Nordisk A/S· Source

  Contact: Novo Nordisk

• Not yet recruiting

  Korean Health Screening-Based Metabolic Dysfunction-Associated Steatotic Liver Disease Registry

  NCT06843421· Korea University· Source

  Contact: Seong Hee Kang, MD., PhD.

• Active, not recruiting

  Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)

  NCT06564142· Phase 3· Alpine Immune Sciences Inc, A Subsidiary of Vertex· Source

• Active, not recruiting

  Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

  NCT04822181· Phase 3· Novo Nordisk A/S· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Heart failure2 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Obesity1 recruiting

Closed trials

• Completed

  Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH)

  NCT05016882· Phase 2· Novo Nordisk A/S· Source

• Completed

  ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation

  NCT05021835· Phase 3· Novo Nordisk A/S· Source